Becton Dickinson, a global medical technology company, completed the acquisition of Tepha, a developer of medical device components. Financial terms were not disclosed. "This strategic acquisition advances BD's category leadership in surgical mesh and enables future innovations to provide new solutions to physicians and their patients. Tepha's proprietary polymer is used in BD's current Phasix™ Mesh products and is the key technology that enables our products to provide short-term support for soft tissue repairs, while enabling rapid tissue ingrowth and reabsorbing into the body over time. The acquisition — including its current and potential applications — will help ensure BD can continually provide physicians with the latest technology to treat their patients," Kevin Kelly, BD President.